Driven by Our Promise
It began with a promise. CSL, was formed more than 100 years ago to save lives using the latest technologies. In the century since, CSL has grown into a global biotechnology leader, driven by that same promise to save and improve lives. We offer the broadest range of quality plasma-derived and recombinant therapies in our industry. Our ability to innovate and deliver life-saving medicines for patients with rare disease and other unmet medical needs around the world has earned us a reputation for always putting patients first. We are CSL and we are driven by our promise.
Areas of Expertise
We focus on rare and serious diseases and influenza vaccines. Today, we compete on the global stage as one of the largest and fastest-growing protein-based biotechnology businesses and a leading provider of in-licensed vaccines.
Rare & Serious Diseases
Our innovations are used around the world to treat immunodeficiencies, bleeding disorders, hereditary angioedema, Alpha 1 antitrypsin deficiency and neurological disorders.
Through our influenza vaccines business, Seqirus, we are a transcontinental partner in pandemic preparedness and a major contributor to the prevention and control of influenza globally.
CSL’s strong commitment to living our Values has guided us for many decades. Our Values have been fundamental to our success — helping us to save lives, protect the health of people, and earn our reputation as a trusted and reliable global leader. They’re at the core of how our employees interact with each other, make decisions and solve problems.
We deliver on our promise to patients.
We turn innovative thinking into solutions.
We walk the talk.
We are stronger together.
We take pride in our results.